Sort
30,917 grants matching “tumor microenvironment”
Project 3: Developing CAR T Cell Therapies to Target Tumor Heterogeneity in Advanced Prostate Cancer
$271,267Owen N Witte · University Of California Los Angeles · P50 · FY2020 · CA
Oligomannose antigens as conserved immunological targets of Non-Hodgkin lymphomas
$271,185Denong Wang · Sri International · R21 · FY2021 · CA
Physical and Chemical Cues in Tumor Cell Migration
$271,173Cynthia A Reinhart-King · Cornell University · U54 · FY2013 · CA
The Molecular Profile of Prostate Tumors in African-American Men
$271,166Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Core C - Cell Culture and iPS Core (CCiC)
$271,162Hiroshi Nakagawa · Columbia University Health Sciences · P01 · FY2021 · CA
Ongoing inflammation following chemotherapy induces immunosuppression
$271,123Chuanlin Ding · University Of Louisville · P20 · FY2022 · GM
OVERCOMING TUMOR EVASION MECHANISMS IN HODGKIN DISEASE
$271,113Cliona M Rooney · Baylor College Of Medicine · P01 · FY2012 · CA
TR&D2
$271,109Thomas D Wang · University Of Michigan At Ann Arbor · P41 · FY2025 · EB
Administrative Core
$271,094Forest M White · Massachusetts Institute Of Technology · U54 · FY2019 · CA
Syndecan-1 in Stromal Fibroblasts of Breast Carcinomas
$271,088Andreas Friedl · University Of Wisconsin-Madison · R01 · FY2013 · CA
Cell-Cell &Cell Stroma Regulation in Oral Premalignancy
$271,069New York University · R01 · FY2004 · DE
Targeting JAK2 Kinase in Lymphoma
$271,040Mamta Gupta · University Of Iowa · P50 · FY2013 · CA
IMMUNOTHERAPY OF COLON CANCER METASTIC TO THE LIVER
$271,006Massachusetts General Hospital · R01 · FY2000 · CA
Role of elF2a phosphorylation and ER stress in hypoxia tolerance and tumor growth
$270,985Constantinos Koumenis · University Of Pennsylvania · R01 · FY2014 · CA
TR&D Project 3
$270,982Jamie Berta Spangler · Johns Hopkins University · P41 · FY2024 · EB
Defining mechanisms of immunotherapy resistance and targeting TIGIT in hepatobiliary cancers
$270,981David Hsieh · Ut Southwestern Medical Center · K08 · FY2025 · CA
Project 2-Metabolic Modulation of Myeloid-Derived Suppressor Cells to Increase Efficacy of Neo adjuvant Chemotherapy and Immunotherapy
$270,954Augusto C Ochoa · Lsu Health Sciences Center · P20 · FY2020 · CA
Molecular Determinants of Tumor Progression in A Steatolic Liver Microenvironment
$270,952David L Gorden · Vanderbilt University · U01 · FY2010 · CA
Regulatory Mechanisms Controlling Breast Tissue Development and Transformation
$270,945Anthony N Imbalzano · University Of Vermont & St Agric College · P01 · FY2015 · CA
Understanding and overcoming Immunotherapy resistance in Pediatric High-Grade Glioma
$270,938Dolores Hambardzumyan · Icahn School Of Medicine At Mount Sinai · R21 · FY2022 · NS
Combinatorial Protein Transfer for Cancer Therapeutics
$270,929Aoshuang Chen · University Of Illinois At Chicago · R01 · FY2006 · CA
Molecular mechanism of cell invasion
$270,900State University New York Stony Brook · R01 · FY2004 · CA
Mesenchymal Derived Growth Factors in Prostatic Cancer
$270,900Baylor College Of Medicine · R01 · FY2005 · CA
Mesenchymal Derived Growth Factors in Prostatic Cancer
$270,900Baylor College Of Medicine · R01 · FY2004 · CA
Molecular mechanism of cell invasion
$270,900State University New York Stony Brook · R01 · FY2005 · CA